Erin Lavelle's Net Worth
$309 Thousand
Who is Erin Lavelle?
Erin Lavelle does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, Eliem Therapeutics, Inc., and Neoleukin Therapeutics, Inc..
SEC CIK
Erin Lavelle's CIK is 0001737613
Past Insider Trading and Trends
2019 was Erin Lavelle's most active year for acquiring shares with 3 total transactions. Erin Lavelle's most active month to acquire stocks was the month of March. 2019 was Erin Lavelle's most active year for disposing of shares, totalling 4 transactions. Erin Lavelle's most active month to dispose stocks was the month of September. 2018 saw Erin Lavelle paying a total of $0.00 for 300,000 shares, this is the most they've acquired in one year. In 2019 Erin Lavelle cashed out on 467,526 shares for a total of $309,255.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.41K |
$18.00 | -$289,656.00 |
0
|
Oct 22
| |||
Form 4
|
∞
| 4.41K |
$13.67 | -$19,599.34 | 4.41K |
Scheduled
|
Apr 23 - Apr 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eliem Therapeutics, Inc. (ELYM) Snapshot price: $2.62
COO & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neoleukin Therapeutics, Inc. (NLTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
| No matching records found | |||||||||